Feb 14, 2019 - TEVA earnings call for the period ending December 31, 2018.
Feb 14, 2019 -
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) reported disappointing fourth-quarter earnings Wednesday before the market open, sending its shares down about 8 percent.
Feb 14, 2019 - Teva's (TEVA) fourth-quarter earnings miss estimates while sales marginally beat expectations. Guidance for 2019 is lower than expected.
Feb 13, 2019 - Find out what made these stocks lose ground despite a good session for the markets.
Feb 13, 2019 - Here are the key takeaways from Eli Lilly's (LLY) fourth-quarter earnings conference call.
Feb 13, 2019 - Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Q4 2018 Earnings Conference Call February 13, 2019, 08:00 ET Company Participants Kevin Mannix - Head, Global IR & VP Kare Schultz - President, CEO &
Feb 13, 2019 - Names on the move ahead of the open.
Feb 13, 2019 - Teva Pharmaceutical Industries (TEVA -7.8%) chief Kåre Schultz told Reuters that he is "content" with 2/3 of U.S. insurers covering Ajovy (fremanezumab-vfrm) because he does not want to be ove
Feb 13, 2019 - The S&P 500 currently trades higher by 0.5%, and the Russell 2000 trades higher...
Feb 13, 2019 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2018 Q4 earnings call.